Following primary infection Herpes simplex virus-1 (HSV-1) establishes lifelong latency in the neurons of human sensory ganglia. Upon reactivation HSV-1 can cause neurological diseases such as facial palsy, vestibular neuritis or encephalitis. Certain populations of sensory neurons have been shown to be more susceptible to latent infection in the animal model, but this has not been addressed in human tissue. In the present study, trigeminal ganglion (TG) neurons expressing six neuronal marker proteins were characterized, based on staining with antibodies against the GDNF family ligand receptor Ret, the high-affinity nerve growth factor receptor TrkA, neuronal nitric oxide synthase (nNOS), the antibody RT97 against 200kDa neurofilament, calcitonin gene-related peptide and peripherin. The frequencies of marker-positive neurons and their average neuronal sizes were assessed, with TrkA-positive (61.82%) neurons being the most abundant, and Ret-positive (26.93%) the least prevalent. Neurons positive with the antibody RT97 (1253 μm2) were the largest, and those stained against peripherin (884 μm2) were the smallest. Dual immunofluorescence revealed at least a 4.5% overlap for every tested marker combination, with overlap for the combinations TrkA/Ret, TrkA/RT97 and Ret/nNOS lower, and the overlap between Ret/CGRP being higher than would be expected by chance. With respect to latent HSV-1 infection, latency associated transcripts (LAT) were detected using in situ hybridization (ISH) in neurons expressing each of the marker proteins. In contrast to the mouse model, co-localization with neuronal markers Ret or CGRP mirrored the magnitude of these neuron populations, whereas for the other four neuronal markers fewer marker-positive cells were also LAT-ISH+. Ret and CGRP are both known to label neurons related to pain signaling.
References
[1]
Griffin BD, Verweij MC, Wiertz EJ (2010) Herpesviruses and immunity: the art of evasion. VetMicrobiol 143: 89–100.
[2]
Wilson AC, Mohr I (2012) A cultured affair: HSV latency and reactivation in neurons. Trends Microbiol 20: 604–611.
[3]
Held K, Derfuss T (2011) Control of HSV-1 latency in human trigeminal ganglia-current overview. JNeurovirol 17: 518–527.
[4]
Stevens JG, Wagner EK, vi-Rao GB, Cook ML, Feldman LT (1987) RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons. Science 235: 1056–1059.
[5]
Thompson RL, Sawtell NM (1997) The herpes simplex virus type 1 latency-associated transcript gene regulates the establishment of latency. JVirol 71: 5432–5440.
[6]
Perng GC, Slanina SM, Yukht A, Ghiasi H, Nesburn AB, et al. (2000) The latency-associated transcript gene enhances establishment of herpes simplex virus type 1 latency in rabbits. J Virol 74: 1885–1891.
[7]
Hill JM, Sedarati F, Javier RT, Wagner EK, Stevens JG (1990) Herpes simplex virus latent phase transcription facilitates in vivo reactivation. Virology 174: 117–125.
[8]
Perng GC, Dunkel EC, Geary PA, Slanina SM, Ghiasi H, et al. (1994) The latency-associated transcript gene of herpes simplex virus type 1 (HSV-1) is required for efficient in vivo spontaneous reactivation of HSV-1 from latency. J Virol 68: 8045–8055.
[9]
Perng GC, Jones C, Ciacci-Zanella J, Stone M, Henderson G, et al. (2000) Virus-induced neuronal apoptosis blocked by the herpes simplex virus latency-associated transcript. Science 287: 1500–1503.
[10]
Steiner I, Kennedy PG, Pachner AR (2007) The neurotropic herpes viruses: herpes simplex and varicella-zoster. Lancet Neurol 6: 1015–1028.
[11]
Steiner I, Kennedy PG (1995) Herpes simplex virus latent infection in the nervous system. JNeurovirol 1: 19–29.
[12]
Thompson RL, Preston CM, Sawtell NM (2009) De novo synthesis of VP16 coordinates the exit from HSV latency in vivo. PLoSPathog 5: e1000352.
[13]
Sheridan BS, Knickelbein JE, Hendricks RL (2007) CD8 T cells and latent herpes simplex virus type 1: keeping the peace in sensory ganglia. ExpertOpinBiolTher 7: 1323–1331.
[14]
Mark KE, Wald A, Magaret AS, Selke S, Kuntz S, et al. (2010) Rapidly cleared episodes of oral and anogenital herpes simplex virus shedding in HIV-infected adults. JAcquirImmuneDeficSyndr 54: 482–488.
[15]
Wauters O, Lebas E, Nikkels AF (2012) Chronic mucocutaneous herpes simplex virus and varicella zoster virus infections. JAm AcadDermatol 66: e217–e227.
[16]
Theil D, Derfuss T, Paripovic I, Herberger S, Meinl E, et al. (2003) Latent herpesvirus infection in human trigeminal ganglia causes chronic immune response. AmJ Pathol 163: 2179–2184.
[17]
Sommer EW, Kazimierczak J, Droz B (1985) Neuronal subpopulations in the dorsal root ganglion of the mouse as characterized by combination of ultrastructural and cytochemical features. Brain Res 346: 310–326.
[18]
Margolis TP, Imai Y, Yang L, Vallas V, Krause PR (2007) Herpes simplex virus type 2 (HSV-2) establishes latent infection in a different population of ganglionic neurons than HSV-1: role of latency-associated transcripts. J Virol 81: 1872–1878.
[19]
Kai-Kai MA (1989) Cytochemistry of the trigeminal and dorsal root ganglia and spinal cord of the rat. Comp BiochemPhysiol A Comp Physiol 93: 183–193.
[20]
Lazarov NE (2002) Comparative analysis of the chemical neuroanatomy of the mammalian trigeminal ganglion and mesencephalic trigeminal nucleus. ProgNeurobiol 66: 19–59.
[21]
Yang L, Voytek CC, Margolis TP (2000) Immunohistochemical analysis of primary sensory neurons latently infected with herpes simplex virus type 1. JVirol 74: 209–217.
[22]
Margolis TP, Dawson CR, LaVail JH (1992) Herpes simplex viral infection of the mouse trigeminal ganglion. Immunohistochemical analysis of cell populations. Invest OphthalmolVisSci 33: 259–267.
[23]
Bertke AS, Swanson SM, Chen J, Imai Y, Kinchington PR, et al. (2011) A5-positive primary sensory neurons are nonpermissive for productive infection with herpes simplex virus 1 in vitro. JVirol 85: 6669–6677.
[24]
Theil D, Arbusow V, Derfuss T, Strupp M, Pfeiffer M, et al. (2001) Prevalence of HSV-1 LAT in human trigeminal, geniculate, and vestibular ganglia and its implication for cranial nerve syndromes. Brain Pathol 11: 408–413.
[25]
Aurelius E, Johansson B, Skoldenberg B, Staland A, Forsgren M (1991) Rapid diagnosis of herpes simplex encephalitis by nested polymerase chain reaction assay of cerebrospinal fluid. Lancet 337: 189–192.
[26]
Aurelius E, Johansson B, Skoldenberg B, Forsgren M (1993) Encephalitis in immunocompetent patients due to herpes simplex virus type 1 or 2 as determined by type-specific polymerase chain reaction and antibody assays of cerebrospinal fluid. JMedVirol 39: 179–186.
[27]
Held K, Junker A, Dornmair K, Meinl E, Sinicina I, et al. (2011) Expression of herpes simplex virus 1-encoded microRNAs in human trigeminal ganglia and their relation to local T-cell infiltrates. JVirol 85: 9680–9685.
[28]
Wang K, Lau TY, Morales M, Mont EK, Straus SE (2005) Laser-capture microdissection: refining estimates of the quantity and distribution of latent herpes simplex virus 1 and varicella-zoster virus DNA in human trigeminal Ganglia at the single-cell level. JVirol 79: 14079–14087.
[29]
Zerboni L, Sobel RA, Lai M, Triglia R, Steain M, et al. (2012) Apparent expression of varicella-zoster virus proteins in latency resulting from reactivity of murine and rabbit antibodies with human blood group a determinants in sensory neurons. JVirol 86: 578–583.
[30]
Quartu M, Setzu MD, Del FM (1996) trk-like immunoreactivity in the human trigeminal ganglion and subnucleus caudalis. Neuroreport 7: 1013–1019.
[31]
Quartu M, Geic M, Del FM (1997) Neurotrophin-like immunoreactivity in the human trigeminal ganglion. Neuroreport 8: 3611–3617.
[32]
Fang X, Djouhri L, McMullan S, Berry C, Okuse K, et al. (2005) trkA is expressed in nociceptive neurons and influences electrophysiological properties via Nav1.8 expression in rapidly conducting nociceptors. JNeurosci 25: 4868–4878.
[33]
Gaspersic R, Kovacic U, Cor A, Skaleric U (2007) Expression of TrkA receptor for neurotrophins in trigeminal neurons innervating the rat gingivomucosal tissue. NeurosciLett 418: 253–256.
[34]
Quartu M, Serra MP, Mascia F, Boi M, Lai ML, et al. (2006) GDNF family ligand receptor components Ret and GFRalpha-1 in the human trigeminal ganglion and sensory nuclei. Brain ResBull 69: 393–403.
[35]
Molliver DC, Wright DE, Leitner ML, Parsadanian AS, Doster K, et al. (1997) IB4-binding DRG neurons switch from NGF to GDNF dependence in early postnatal life. Neuron 19: 849–861.
[36]
Felipe CD, Gonzalez GG, Gallar J, Belmonte C (1999) Quantification and immunocytochemical characteristics of trigeminal ganglion neurons projecting to the cornea: effect of corneal wounding. EurJPain 3: 31–39.
[37]
Quartu M, Diaz G, Floris A, Lai ML, Priestley JV, et al. (1992) Calcitonin gene-related peptide in the human trigeminal sensory system at developmental and adult life stages: immunohistochemistry, neuronal morphometry and coexistence with substance P. JChemNeuroanat. 5: 143–157.
[38]
Alvarez FJ, Morris HR, Priestley JV (1991) Sub-populations of smaller diameter trigeminal primary afferent neurons defined by expression of calcitonin gene-related peptide and the cell surface oligosaccharide recognized by monoclonal antibody LA4. JNeurocytol 20: 716–731.
[39]
Vang H, Chung G, Kim HY, Park SB, Jung SJ, et al. (2012) Neurochemical properties of dental primary afferent neurons. ExpNeurobiol 21: 68–74.
[40]
Flores CM, DeCamp RM, Kilo S, Rogers SW, Hargreaves KM (1996) Neuronal nicotinic receptor expression in sensory neurons of the rat trigeminal ganglion: demonstration of alpha3beta4, a novel subtype in the mammalian nervous system. JNeurosci 16: 7892–7901.
[41]
Price TJ, Flores CM (2007) Critical evaluation of the colocalization between calcitonin gene-related peptide, substance P, transient receptor potential vanilloid subfamily type 1 immunoreactivities, and isolectin B4 binding in primary afferent neurons of the rat and mouse. J Pain 8: 263–272.
[42]
Bergman E, Carlsson K, Liljeborg A, Manders E, Hokfelt T, et al. (1999) Neuropeptides, nitric oxide synthase and GAP-43 in B4-binding and RT97 immunoreactive primary sensory neurons: normal distribution pattern and changes after peripheral nerve transection and aging. Brain Res 832: 63–83.
Arbusow V, Derfuss T, Held K, Himmelein S, Strupp M, et al. (2010) Latency of herpes simplex virus type-1 in human geniculate and vestibular ganglia is associated with infiltration of CD8+ T cells. JMedVirol 82: 1917–1920.
[45]
Rusu MC, Pop F, Hostiuc S, Dermengiu D, Lala AI, et al. (2011) The human trigeminal ganglion: c-kit positive neurons and interstitial cells. AnnAnat 193: 403–411.
[46]
Hufner K, Horn A, Derfuss T, Glon C, Sinicina I, et al. (2009) Fewer latent herpes simplex virus type 1 and cytotoxic T cells occur in the ophthalmic division than in the maxillary and mandibular divisions of the human trigeminal ganglion and nerve. JVirol 83: 3696–3703.
[47]
Harbour DA, Hill TJ, Blyth WA (1983) Recurrent herpes simplex in the mouse: inflammation in the skin and activation of virus in the ganglia following peripheral stimulation. JGenVirol 64 (Pt 7): 1491–1498.
[48]
Feldman LT, Ellison AR, Voytek CC, Yang L, Krause P, et al. (2002) Spontaneous molecular reactivation of herpes simplex virus type 1 latency in mice. ProcNatlAcadSciUSA 99: 978–983.
[49]
Perng GC, Slanina SM, Yukht A, Ghiasi H, Nesburn AB, et al. (1999) Herpes simplex virus type 1 serum neutralizing antibody titers increase during latency in rabbits latently infected with latency-associated transcript (LAT)-positive but not LAT-negative viruses. J Virol 73: 9669–9672.
[50]
Hilliges M, Astback J, Wang L, Arvidson K, Johansson O (1996) Protein gene product 9.5-immunoreactive nerves and cells in human oral mucosa. AnatRec 245: 621–632.
[51]
Golden JP, Hoshi M, Nassar MA, Enomoto H, Wood JN, et al. (2010) RET signaling is required for survival and normal function of nonpeptidergic nociceptors. JNeurosci 30: 3983–3994.
[52]
Quartu M, Setzu MD, Del Fiacco M (1996) trk-like immunoreactivity in the human trigeminal ganglion and subnucleus caudalis. Neuroreport 7: 1013–1019.
[53]
Sniderhan LF, Garcia-Bates TM, Burgart M, Bernstein SH, Phipps RP, et al. (2009) Neurotrophin signaling through tropomyosin receptor kinases contributes to survival and proliferation of non-Hodgkin lymphoma. Exp Hematol 37: 1295–1309.
[54]
Borsani E, Giovannozzi S, Boninsegna R, Rezzani R, Labanca M, et al. (2010) Nitroxidergic system in human trigeminal ganglia neurons: a quantitative evaluation. Acta Histochem 112: 444–451.
[55]
Price J (1985) An immunohistochemical and quantitative examination of dorsal root ganglion neuronal subpopulations. JNeurosci 5: 2051–2059.
[56]
Eftekhari S, Salvatore CA, Calamari A, Kane SA, Tajti J, et al. (2010) Differential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglion. Neuroscience 169: 683–696.
[57]
Xiao S, McLean J, Robertson J (2006) Neuronal intermediate filaments and ALS: a new look at an old question. Biochim Biophys Acta 1762: 1001–1012.
[58]
Lariviere RC, Nguyen MD, Ribeiro-da-Silva A, Julien JP (2002) Reduced number of unmyelinated sensory axons in peripherin null mice. JNeurochem 81: 525–532.
[59]
Xiao S, McLean J, Robertson J (2006) Neuronal intermediate filaments and ALS: a new look at an old question. BiochimBiophysActa 1762: 1001–1012.
